NEUWAY Pharma

BiotechnologySeries BBonn, Germany

Latest round

Series B

Last raised

Aug 2023

Total raised

$8.1M

Investors

6

About NEUWAY Pharma

Based in Bonn, Germany, and founded in 2014, Neuway Pharma GmbH is a spin-off from Life Science Inkubator (LSI) GmbH that engages in pre-clinical and clinical development of therapeutics for treatment of orphan brain diseases. Neuway Pharma develops mRNA-based therapies for rare central nervous system (CNS) diseases using its proprietary EnPC® (Engineered Protein Capsules) delivery platform. The company’s lead candidate targets Metachromatic Leukodystrophy (MLD), a rare lysosomal storage disorder, by delivering mRNA encoding for the missing enzyme Arylsulfatase. The firm’s EnPC® capsules enable targeted delivery to brain cells, overcoming the blood-brain barrier.

Who invested in NEUWAY Pharma

6 investors across 4 rounds

See all investors in NEUWAY Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 9, 2023

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Apr 27, 2023

    Amount

    $1M

    Investors

    Locked

  3. Series A

    Oct 29, 2015

    Amount

    $3.5M

    Investors

    Locked

  4. Series A

    May 27, 2014

    Amount

    $3.7M

    Investors

    Locked

Questions about NEUWAY Pharma

Who invested in NEUWAY Pharma?

NEUWAY Pharma has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has NEUWAY Pharma raised?

NEUWAY Pharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did NEUWAY Pharma last raise money?

NEUWAY Pharma's most recent round on record is a Series B, in Aug 2023.

What does NEUWAY Pharma do?

Based in Bonn, Germany, and founded in 2014, Neuway Pharma GmbH is a spin-off from Life Science Inkubator (LSI) GmbH that engages in pre-clinical and clinical development of therapeutics for treatment of orphan brain diseases.

Where is NEUWAY Pharma headquartered?

NEUWAY Pharma is headquartered in Bonn, Germany.

Which VCs invest in companies like NEUWAY Pharma?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at NEUWAY Pharma's stage. Their profiles are linked below.

Raising like NEUWAY Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.